Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stockholm - Delayed Quote SEK

Cline Scientific AB (publ) (CLINE-B.ST)

Compare
0.0690
0.0000
(0.00%)
At close: August 9 at 3:00:00 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
3.9910
116.5830
Cost of Revenue
-4,104.1870
-4,104.1870
-2,824.7680
-2,855.5610
-2,365.4740
Gross Profit
4,104.1870
4,104.1870
2,824.7680
2,859.5520
2,482.0570
Operating Expense
7,213.0480
7,213.0480
5,141.8290
6,363.2460
4,128.5670
Operating Income
-3,108.8610
-3,108.8610
-2,317.0610
-3,503.6940
-1,646.5100
Net Non Operating Interest Income Expense
-39.1110
-39.1110
-18.2200
-33.0840
-192.8070
Pretax Income
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Net Income Common Stockholders
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Diluted NI Available to Com Stockholders
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Basic EPS
-0.10
-0.07
-0.10
-0.19
-0.12
Diluted EPS
-0.10
-0.07
-0.10
-0.19
-0.12
Basic Average Shares
23,763.9020
45,009.6850
23,763.9010
19,055.2150
19,055.2150
Diluted Average Shares
23,763.9020
45,009.6850
23,763.9010
19,055.2150
19,055.2150
Total Operating Income as Reported
-3,108.8610
-3,108.8610
-2,317.0610
-3,503.6940
-1,780.6230
Total Expenses
3,108.8610
3,108.8610
2,317.0610
3,507.6850
1,763.0930
Net Income from Continuing & Discontinued Operation
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Normalized Income
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Interest Income
0.0010
0.0010
--
--
--
Interest Expense
39.1120
39.1120
18.2200
33.0840
192.8070
Net Interest Income
-39.1110
-39.1110
-18.2200
-33.0840
-192.8070
EBIT
-3,108.8600
-3,108.8600
-2,317.0610
-3,503.6940
-1,646.5100
EBITDA
-3,096.1600
-3,096.1600
-2,304.3610
-3,486.0700
-1,628.8730
Reconciled Cost of Revenue
-4,104.1870
-4,104.1870
-2,824.7680
-2,855.5610
-2,365.4740
Reconciled Depreciation
12.7000
12.7000
12.7000
17.6240
17.6370
Net Income from Continuing Operation Net Minority Interest
-3,147.9720
-3,147.9720
-2,335.2810
-3,536.7780
-1,839.3170
Normalized EBITDA
-3,096.1600
-3,096.1600
-2,304.3610
-3,486.0700
-1,628.8730
12/31/2020 - 3/30/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1398
+31.64%
 
LYTIX.OL Lytix Biopharma AS
4.9500
+3.99%
 
ELIC.ST Elicera Therapeutics AB (publ)
2.5400
+7.63%
 
ABLI.ST Abliva AB (publ)
0.4420
-2.00%
 
KAN.ST Kancera AB (publ)
1.3200
+14.19%
 
BIOVIC-B.ST Biovica International AB (publ)
1.8720
-1.47%
 
FLUI.ST Fluicell AB (publ)
0.0408
-5.99%
 
ATORX.ST Alligator Bioscience AB (publ)
0.0111
-76.73%
 
SANION.ST Saniona AB (publ)
7.28
0.00%